Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 11
Submit an article Journal homepage
221
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

Outcomes of acute myeloid leukemia with t(15;17) not associated with acute promyelocytic leukemia

Amy SoniDepartment of Medicine, Division of Hematology/Oncology,University of Pittsburgh School of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
,
Miroslav DjokicDepartment of Pathology, Division of Hematopathology, University of Pittsburgh School of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
,
Jing-Zhou HouDepartment of Medicine, Division of Hematology/Oncology,University of Pittsburgh School of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
,
Robert L. RednerDepartment of Medicine, Division of Hematology/Oncology,University of Pittsburgh School of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
&
Michael BoyiadzisDepartment of Medicine, Division of Hematology/Oncology,University of Pittsburgh School of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USACorrespondence[email protected]
Pages 3236-3239 | Received 17 Mar 2015, Accepted 24 Mar 2015, Published online: 20 May 2015

References

  • Swerdlow SH, Cancer IAfRo, Organization WH. WHO classification of tumours of haematopoietic and lymphoid tissues. International Agency for Research on Cancer; 2008.
  • Craig FE, Foon KA. Flow cytometric immunophenotyping for hematologic neoplasms. Blood 2008;111:3941–3967.
  • de The H, Chomienne C, Lanotte M, et al. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 1990;347:558–561.
  • Melnick A, Licht JD. Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 1999;93:3167–3215.
  • Cotter M, Enright H. A novel t(15;17) translocation in acute myeloid leukaemia not associated with PML/RARalpha rearrangement. Clin Lab Haematol 2003;25:255–257.
  • Di Bona E, Montaldi A, Guercini N, et al. A (15;17) translocation not associated with acute promyelocytic leukaemia. Br J Haematol 1996;95:706–709.
  • Kwan Ma ES, Au W, Kong Wan TS, et al. Translocation (15;17)(q22;q21) not associated with acute promyelocytic leukemia and negative for PML/RARa rearrangement. Haematologica 2000;85: 768–769.
  • Li S, Zhang L, Kern WF, et al. Identification of t(15;17) and a segmental duplication of chromosome 11q23 in a patient with acute myeloblastic leukemia M2. Cancer Genet Cytogenet 2002;138: 149–152.
  • Varella-Garcia M, Brizard F, Roche J, et al. Aml1/ETO and Pml/RARA rearrangements in a case of AML-M2 acute myeloblastic leukemia with t(15;17). Leuk Lymphoma 1999;33:403–406.
  • Allford S, Grimwade D, Langabeer S, et al. Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARalpha rearrangement in newly diagnosed AML. The Medical Research Council (MRC) Adult Leukaemia Working Party. Br J Haematol 1999;105:198–207.
  • Tallman MS, Andersen JW, Schiffer CA, et al. All-trans-retinoic acid in acute promyelocytic leukemia. N Engl J Med 1997;337: 1021–1028.
  • Sanz MA, Montesinos P, Rayon C, et al. Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome. Blood 2010;115:5137–5146.
  • Hu J, Liu YF, Wu CF, et al. Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia. Proc Natl Acad Sci USA 2009;106:3342–3347.
  • Lo-Coco F, Avvisati G, Vignetti M, et al. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N Engl J Med 2013;369:111–121.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.